Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
International Cooperative Ataxia Rating Scale (ICARS)
87%
Transcriptome
76%
Tumor
61%
MiRNome
54%
Tumor Samples
52%
Heterogeneous Tumors
47%
Deconvolution
39%
Gene Expression
37%
Cancer Patients
35%
MicroRNA
35%
Glioblastoma
33%
Bulk Samples
28%
Stromal Cells
28%
Brain Glioma
23%
Gene Isoforms
23%
Deconvolution Visualization
23%
Complex DNA Mixtures
23%
Parallel Technique
23%
Patient Classification
23%
Biological Knowledge
23%
Publicly Available Data
23%
Feature Selection Methods
23%
Cancer Diagnosis
23%
Bulk Tissue
23%
Massive Parallelism
23%
Tissue Analysis
23%
Cell Subtypes
23%
Cell Population
23%
Bulk Transcriptome
23%
Cellular Level
23%
Clinical Issues
23%
Microarray
23%
Research Discovery
23%
Expression Data
23%
Non-small Cell Lung Cancer (NSCLC)
23%
Exon Junction
23%
Therapeutic Target
23%
DNA Methylation Profiling
23%
Cell Cycle Genes
23%
DNA Repair
23%
Primary Glioblastoma
23%
Cancer Omics Data
23%
Reference-based Deconvolution
23%
CRISPR Screen
23%
Gene Signature
23%
Recurrent Glioblastoma
23%
Prototypical Exemplars
23%
Prognostic Value
23%
Patient Avatars
23%
High-throughput Data
23%
Glioma Invasion
23%
Zinc Finger Protein
23%
Omics Dataset
23%
Biological Processes
23%
Integrative Approach
23%
Cytokine Stimulation
23%
Recurrent Glioma
23%
Cancer Cells
23%
Transcriptional Profiling
23%
RNA Species
23%
Primary Glioma
23%
Transcriptional Regulator
23%
Process Outcomes
23%
Clinical Outcomes
23%
Orthotopic Xenograft
23%
Patient-derived Organoids
23%
Cancer Types
23%
Melanoma Patients
23%
Transcriptomic Data
23%
RNA Interference
23%
Precision Oncology
23%
Glioma
23%
Patient-derived Xenograft
19%
Transcriptional Network
19%
Expression Level
19%
Radiotherapy
17%
Technical Bias
17%
Temozolomide
15%
Zinc Finger
15%
Clinically Significant
13%
Gene Expression Profile
11%
MiRNA Transcriptome
11%
Expression Profile
11%
Colon
11%
Gene Regulation
11%
Interleukin-27 (IL-27)
11%
Tissue Origin
11%
Organoids
11%
Cell Signaling Networks
11%
Neoplastic Cells
11%
High Fold
11%
Transcriptomic Response
11%
Skin Tissue
11%
Response to Pathogens
11%
Liver Cells
11%
Role in Cancer
11%
Liver Tissue
11%
Tumor-associated
11%
Non-neoplastic
11%
Cytokine Response
11%
Colon Tissue
11%
Responsive Genes
11%
Patient Survival
11%
Inflammatory Process
11%
Hepatocarcinogenesis
11%
Cytokine Levels
11%
Liver
11%
Type-specific
10%
Primary Tumor
9%
Publicly Available
9%
Tumor Biology
9%
Deconvolution Method
9%
Omics Data
8%
Network Dataset
7%
Systematic Perspective
7%
Available Technologies
7%
Genotype Interactions
7%
Pooled Screen
7%
CRISPR-associated Protein 9 (Cas9)
7%
Mechanistic Levels
7%
Invasion Genes
7%
Data-driven Methods
7%
Coding RNA
7%
MiRNA Target Genes
7%
Targetome
7%
Overexpression
7%
PIWI-interacting RNA (piRNA)
7%
Transcriptome-wide
7%
Target Gene Prediction
7%
Non-coding RNA (ncRNA)
7%
Blood-brain Barrier
7%
Long Non-coding RNA (LncRNA)
7%
Cellular Model
7%
Gene Function
7%
CRISPR Activation
7%
Primary Brain Tumor
7%
Protein Complex
7%
Murine Double Minute 2 (MDM2)
7%
Computational Approach
7%
Gene Transcription
7%
Genotype-phenotype
7%
Gene Phenotypes
7%
Motility
7%
Sequencing Technology
7%
Systemic Treatment
7%
Cas9 Protein
7%
High-throughput Genetic Screen
7%
Technology-based
7%
Nuclear Localization
7%
Nuclear Proteins
7%
NrCAM
7%
COL6A2
7%
Surgical Mask
7%
RNA Sequencing (RNA-seq)
7%
Radical Surgical Resection
7%
Cyclin-dependent Kinase 4 (CDK4)
7%
Invasive Ability
7%
In Silico Analysis
7%
Invasive Cancer
7%
Tumor Cells
7%
Isocitrate Dehydrogenase 1 (IDH1)
7%
Patient-derived
7%
Post-transcriptional Regulator
7%
Data Preprocessing
6%
Methylome
6%
Specific Vulnerability
5%
DNA Repair Pathways
5%
Group-specific
5%
Genotoxic Damage
5%
Cell Cycle Machinery
5%
Genotoxic Agents
5%
Inefficacy
5%
Pathway Knowledge
5%
DNA Damage
5%
DNA Damage Response
5%
DNA Hypomethylating Agents
5%
Tumor Recurrence
5%
Progression-free Survival
5%
New Targets
5%
Expression Pattern
5%
Chemotherapy
5%
Tumor Development
5%
Standard of Care
5%
Parallel Consensus
5%
Small Cohorts
5%
Mutual Dependency
5%
Median Survival
5%
Gene Expression Analysis
5%
Personalized Therapeutics
5%
Newly Diagnosed Glioblastoma
5%
Cell Proliferation
5%
Biological Function
5%
Immune Cells
5%
Immune Response
5%
Treatment Options
5%
Patient Characteristics
5%
Clinically Meaningful Outcomes
5%
Signal Deconvolution
5%
Patient Samples
5%
Biological Cells
5%
Biochemistry, Genetics and Molecular Biology
Transcriptome
100%
Gene Expression
49%
Methylome
32%
Messenger RNA
31%
MicroRNA
31%
Stromal Cell
28%
Feature Extraction
28%
Transcriptomics
23%
Gene Expression Profiling
23%
RNA
23%
RNA Interference
23%
Biological Phenomena and Functions Concerning the Entire Organism
23%
CRISPR
23%
Zinc Finger Motif
23%
Epidermal Growth Factor Receptor
23%
Exon
23%
Isoform
23%
Patient Coding
23%
Cell Cycle
23%
DNA Methylation
23%
DNA Repair
23%
DnaA
23%
Dimensionality Reduction
23%
Principal Component Analysis
23%
Proteome
23%
Functional Magnetic Resonance Imaging
23%
Promoter Region
19%
Genetics
15%
IDH1
15%
Immunocompetent Cell
12%
Nuclear Protein
11%
Protein Complexes
11%
Genetic Transcription
11%
Blood Brain Barrier
11%
COL6A2
11%
Essential Gene
11%
DNA Damage Response
11%
Gene Signature
11%
Methylation
9%
Genotyping
7%
Vascularization
7%
Platelet Derived Growth Factor Receptor Alpha
7%
Candidate Gene
7%
CRISPR/Cas9
7%
Clinical Trial
7%
Alpha Thalassemia/Mental Retardation X-Linked
7%
Genetic Screen
7%
Biological Functions
7%
Clonal Evolution
7%
Drug Response
7%
Angiogenesis
7%
Cell Proliferation
7%
Gene Function
7%
Immune Response
7%
Cyclin-Dependent Kinase
7%
Cancer Model
7%
Cyclin Dependent Kinase Inhibitor 2A
7%
Rat
7%
Piwi-Interacting RNA
5%
Non-Coding RNA
5%
Expression Level
5%
Small Interfering RNA
5%
Progression Free Survival
5%